Oramed Pharmaceuticals Inc. (ORMP): Cash & Equivalents
$45.95M
As of 2025-12-31
$15.24M
As of 2026-06-30
+4.3%
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $45.95M | -15.6% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $54.42M | +501.0% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $9.05M | -77.6% | 2024-03-06, Balance as of period end |
| 2022-12-31 | $40.46M | n/a | 2024-03-06, Balance as of period end |
| No annual figure between 2021-08-31 and 2022-12-31. | |||
| 2021-08-31 | $77.25M | +300.3% | 2021-11-24, Balance as of period end |
| 2020-08-31 | $19.30M | +479.6% | 2021-11-24, Balance as of period end |
| 2019-08-31 | $3.33M | -33.4% | 2020-11-24, Balance as of period end |
| 2018-08-31 | $5.00M | +25.9% | 2019-11-27, Balance as of period end |
| 2017-08-31 | $3.97M | +1.6% | 2019-11-27, Balance as of period end |
| 2016-08-31 | $3.91M | +21.6% | 2018-11-28, Balance as of period end |
| 2015-08-31 | $3.21M | +82.3% | 2017-11-29, Balance as of period end |
| 2014-08-31 | $1.76M | -22.4% | 2016-11-25, Balance as of period end |
| 2013-08-31 | $2.27M | -48.7% | 2015-11-25, Balance as of period end |
| 2012-08-31 | $4.43M | +192.8% | 2014-11-14, Balance as of period end |
| 2011-08-31 | $1.51M | n/a | 2013-11-27, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Oramed Pharmaceuticals Inc. (ORMP) | 2025-12-31 | $45.95M | -15.6% |
| Immuneering Corp (IMRX) | 2025-12-31 | $128.65M | +255.9% |
| Design Therapeutics, Inc. (DSGN) | 2025-12-31 | $16.86M | -25.3% |
| Evolus, Inc. (EOLS) | 2025-12-31 | $53.83M | -38.1% |
| Pliant Therapeutics, Inc. (PLRX) | 2025-12-31 | $45.45M | -36.2% |
| Evommune, Inc. (EVMN) | 2025-12-31 | $44.06M | +171.1% |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | $8.27M | -2.3% |
| Crescent Biopharma, Inc. (CBIO) | 2025-12-31 | $213.19M | +513.2% |
| Abeona Therapeutics Inc. (ABEO) | 2025-12-31 | $78.44M | +235.8% |
Compare ORMP, IMRX, DSGN, EOLS side by side · Screen every company in Pharmaceutical Preparations ↗